Expert Interviews

September 15, 2020

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

July 31, 2020

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

July 29, 2020

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

July 22, 2020

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

July 14, 2020

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.

July 10, 2020

Dr. Cheryl Wisseh, PharmD, zone 5 director of the National Pharmaceutical Association (NPhA) discusses the ways that the current pandemic is displaying and doubling down on long standing disparities in our health care system.

July 07, 2020

Drug Topics interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.

July 03, 2020

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

June 29, 2020

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

June 25, 2020

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

June 23, 2020

Amie Blaszczyk, PharmD, FASHP, CGP, BCPS, associate professor and division head of geriatrics at Texas Tech University Health Sciences Center, explains the factors acting on older adults in long term care, and the response from these facilities.

June 17, 2020

How can we care for our elderly during a pandemic? Pharmacists practicing in long term care settings discuss the changes and response from their facilities, plus insights on a potential treatment specific to older adults for COVID-19.

June 15, 2020

Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

June 09, 2020

Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

June 05, 2020

Julie Ann Justo, PharmD, infectious diseases clinical pharmacist and assistant professor at the University of South Carolina College of Pharmacy, discusses the treatment potential for remdesivir for SARS-CoV-2, as well as distribution strategies for the drug.

June 03, 2020

Carla Cox, PhD, registered dietician and certified diabetes educator, discusses key information about COVID-19 that individuals with diabetes should know.

May 26, 2020

In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.

May 22, 2020

In part 2 of our interview, Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), discussed the results of their recent survey, which found that many pharmacists and pharmacy technicians feel unsafe from COVID-19 at their workplaces.

May 20, 2020

Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), joined Drug Topics® to discuss their recent survey that pinpointed where pharmacists are feeling most unprotected during the pandemic.

May 15, 2020

In part 2 of our interview, Devin English, assistant professor at Rutgers School of Health, joined Drug Topics® to discuss how COVID-19 is disproportionately affecting minorities.